RARA CRAFT DATABASE for FDA Medical Devices
510(k)K222201

FDA DEVICE FACTS

Biological Feedback and Stimulation System

Medlander Medical Technology, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEOctober 21, 2022PRODUCT CODEIPF

Indications for use

As a powered muscle stimulator the Biological Feedback and Stimulation System is indicated for thefollowing conditions: @ Relaxation of muscle spasm @ Prevention or retardation of disuse atrophy @ Increasing local blood circulation @ Muscle re-education @ Immediate post-surgical stimulation of calf muscles to prevent venous thrombosis @ Maintaining or increasing range of motion As a biofeedback device the Biological Feedback and Stimulation Systemis indicated for thefollowing conditions: @ Biofeedback, relaxationand muscle re-education purposes As a nonimplanted electrical continence device the Biological Feedback and Stimulation Systemisindicated for the following conditions: ® Acute and ongoing treatment of stress, urge or mixed urinary incontinence and where the following results may improve urinary control: Inhibition of the detrusor muscles through reflexive mechanisms and strengthening of pelvic floor muscles. @ Incontinence treatment for assessing EMG activity of the pelvic floor and accessory muscles such as the abdominal and the gluteus muscles.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 22, 2026